ITGAX and neoplasm: Analysis of the TME demonstrated that DS treatment substantially increased the infiltration of tumor-infiltrating type I conventional dendritic cells (cDC1s), identified as CD103+ CD11c+ DCs, and natural killer T (NKT) cells (NK1.1+ CD3+ CD45+) (Fig. 3E and F).